Detalhe da pesquisa
1.
Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy.
Cancer Immunol Res
; 8(11): 1381-1392, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32917659
2.
Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment.
Oncoimmunology
; 9(1): 1708064, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32076578
3.
Prognostic value of IL-6R mRNA in lung adenocarcinoma and squamous cell carcinoma.
Oncol Lett
; 16(3): 2935-2948, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30127882
4.
Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.
PLoS One
; 13(3): e0193428, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29499051
5.
ATF4 Regulates CD4+ T Cell Immune Responses through Metabolic Reprogramming.
Cell Rep
; 23(6): 1754-1766, 2018 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742431